BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 9, 2000
View Archived Issues
Discovery of new generation of ribozymes and compound with potent activity against HER-2 oncogene
Read More
TAP and IPF PharmaCeuticals enter research collaboration
Read More
Basel Institute for Immunology to become a center for medical genomics with Roche support
Read More
AVI BioPharma and collaborators offer key findings for polycystic kidney disease drug development
Read More
Japanese launch of Dovonex ointment imminent
Read More
NovoLog granted FDA approval for treatment of diabetes mellitus
Read More
Interneuron updates clinical and regulatory plans for trospium
Read More
Neurocrine Biosciences advances obesity and diabetes research program
Read More
Bioniche uncovers new class of agents with anticancer activity
Read More
Rat studies demonstrate feasibility of AAV-TNFR:Fc gene therapy in rheumatoid arthritis
Read More
New tryptase inhibitor effective against allergic airways inflammation in animal model
Read More
ICN-10776 reported at Immunology 2000 to induce Th2 cytokine bias
Read More
Data presented this week on antiproliferative activity and mechanism of action of CT-3
Read More
Inflazyme receives investment; advances development programs
Read More
Preliminary pharmacological profile of NMI-377 presented at ASBMB/ASPET 2000
Read More
NO donors revealed as novel therapeutic agents for female sexual dysfunction
Read More
Calyx's new tyrphostin compound exerts both antidiabetic and antiinflammatory effects
Read More
GenVec receives payment for BioByPass milestone
Read More
New thiazole derivatives for inhibiting cell adhesion
Read More
New mGluR1 antagonists claimed by Lilly for migraine and CNS disorders
Read More
Alcon discovers utility of glutamate antagonists for retinal disorders
Read More
Rizatriptan + rofecoxib claimed by Merck for use in migraine
Read More
More effective, better tolerated combinations for migraine
Read More
Orally active and selective COX-2 inhibitors described by Abbott
Read More
Takeda patents new series of somatostatin receptor-modulating aromatic amines
Read More
Vanadium complexes with hypoglycemic and antiproliferative effects
Read More
Cytokine production inhibitors developed by SB for inflammatory disorders
Read More
Pfizer presents new ketolides and use for infections and cancer
Read More
Cortex receives funding to test CX-516 in patients with mild cognitive impairment
Read More